Delivery Order SPE2DB22D1017-SPE2DB24FF5AT
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The potential value of this contract is $8,818.15 and the period of performance runs through March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product from its Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,448,571 units of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The order has a potential value of $2,630.88 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563458687 ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The contract has a potential value of $1,094.52 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering these pharmaceutical products to support military treatment programs and...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 162 mg/0.9 mL ACTEMRA syringes. The $5,618.86 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a broader indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, to supply a range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ACTEMRA 162 mg/0.9 ml syringe, with a potential value of $3,946.26 and a performance period through February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. The $10,523.52 fixed-price contract has an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support federal healthcare programs and services. This award is part of a larger $999,999,999 Indefinite Delivery Contract that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The $1,973.16 contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $3,634.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. This delivery order falls under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,635,723 units of the pharmaceutical product ACTEMRA 200 MG/10 ML VIAL 10ML. This $3,129.96 award has a completion date of February 13, 2024 and was issued on February 12, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor for DLA, providing a wide range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, with a potential value of $6,882.23 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5ATDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,973.16 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and holds a larger indefinite delivery contract with DLA worth up to $999,999,999.00 through December 31, 2025, which allows for the provision of a comprehensive range of medications and medical supplies to military treatment facilities worldwide. This delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization that has been awarded numerous federal contracts from DLA and other agencies to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/28/24 |